A detailed history of Ruedi Wealth Management, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Ruedi Wealth Management, Inc. holds 20 shares of OGN stock, worth $299. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20
Previous 20 -0.0%
Holding current value
$299
Previous $414,000 7.49%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 25, 2024

SELL
$10.95 - $17.32 $120 - $190
-11 Reduced 35.48%
20 $288,000
Q3 2023

Oct 26, 2023

BUY
$16.59 - $23.77 $331 - $475
20 Added 181.82%
31 $538,000
Q4 2022

Feb 21, 2023

BUY
$23.31 - $28.61 $256 - $314
11 New
11 $307,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.8B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Ruedi Wealth Management, Inc. Portfolio

Follow Ruedi Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ruedi Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ruedi Wealth Management, Inc. with notifications on news.